Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first line drug? An observational study of 80 cases

Author: Thakur C. P.   Sinha G. P.   Pandey A. K.   Kumar N.   Kumar P.   Hassan S. M.   Narain S.   Roy R. K.  

Publisher: Routledge Ltd

ISSN: 1364-8594

Source: Annals of Tropical Medicine and Parasitology, Vol.92, Iss.5, 1998-07, pp. : 561-569

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content